Bayamban, Ezekiel H.
HRN: 24-56-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
CEFTRIAXONE 1G (VIAL)
01/08/2025
01/15/2025
INTRAVENOUS
400 Mg
Every 12 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes